Phase 1 Gastroparesis Trial, Recruiting NCT06646913 Sponsor: University of Michigan Condition: Gastroparesis
Back to Gastroparesis

Phase 1 Gastroparesis Trial, Recruiting

NCT06646913
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Systemic Sclerosis (also called scleroderma) based on standard medical classification guidelines.
  • You are 18 years of age or older.
  • You are able to speak and understand English.
  • You experience moderate to severe bloating or a feeling of fullness/distension in your stomach, as measured by a specific questionnaire used in scleroderma research.
  • Any medications you take specifically for gut or digestive problems have remained the same for at least the past 4 weeks.

Who may not be able to join:

  • You are currently pregnant or breastfeeding.
  • You have had major surgery on your abdomen in the past (though removal of the gallbladder or appendix may still be acceptable — confirm with trial site).
  • You have another active condition that could cause abdominal pain, such as inflammatory bowel disease, diabetes, or an unstable thyroid condition.
  • You have a known allergy to the sticky pads used for heart monitor (ECG) electrodes.
  • You have a medical reason why you cannot receive a therapy that uses electrical stimulation near the abdomen, such as having a cardiac pacemaker or a history of epilepsy (confirm with trial site for full list of restrictions).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 734-936-5615

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
1 February 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Tolerability of the TENS device

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov